Oct 20 (Reuters) – Kenvue has urged U.S. regulators to reject a request for a warning of autism on its popular over-the-counter pain medication Tylenol for use during pregnancy, according to a petition. (Reporting by Sriparna Roy in Bengaluru; Editing by Shilpi Majumdar)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)